InvestorsHub Logo
icon url

Executive Order

02/28/20 10:38 PM

#18261 RE: VortMax #18258

Very nice! Plus, this is also an
excerpt from the link I just posted:
(From Alpha Stock News 2/27/20)

The bold blue highlights are the ones that I made & found VERY INTERESTING:

"The idea here is that the company will provide an update with regard to its work with CC Pharming to develop a vaccine. Considering the current climate in the market, this could send the stock soaring. So, short sellers are racing to cover ahead of the news.

Nonetheless, regardless of the company’s work with CC Pharming, it is likely to become a big winner in the coronavirus vaccine space.

That’s because the company owns the FastPharming Facility. Originally part of a government funded program, the FastPharming Facility was created to produce vaccines and biologic agents against pandemic illnesses like COVID-19. In fact, it is the only facility in the United States that has the ability to produce vaccines at the rate at which it can produce them.

As such, no matter who creates the first COVID-19 vaccine, IBIO stands to benefit greatly. First and foremost, the little guys in the race simply don’t have the production capabilities that are required to produce this vaccine. Moreover, the big guys in the race don’t want to give up their valuable production lines to combat the pandemic, losing money via opportunity cost in the process. So, it doesn’t matter which one of them creates the vaccine first, they are going to be looking for manufacturing facilities that can meet demand quickly and keep up thereafter, the FastPharming Facility is one of very few that can do this."

I CAN'T WAIT UNTIL MONDAY NOW!

mwz

IBIO
icon url

trademax42

02/28/20 10:43 PM

#18263 RE: VortMax #18258

Exactly. Wow!! It would be a game changer if the collaboration between iBio Inc and Beijing CC-Pharming leads to the development of a new vaccine for coronavirus. In that case this ticker could take the market by storm.

Exciting to read this:

“This is an important collaboration to develop plant-derived vaccine strategies for the emerging coronavirus outbreak here in China, and around the world. iBio’s capabilities will enhance our ability to rapidly scale-up vaccine candidate production in effort to combat the 2019-nCoV virus’ threat to global health.”

https://seekingalpha.com/pr/17767304-ibio-and-cc-pharming-initiate-joint-development-of-coronavirus-vaccine

$IBIO

all Imho only